Moore, Kathleen N <br/><br/>
A review of mirvetuximab soravtansine in the treatment of platinum-resistant ovarian cancer.  [electronic resource] 

 -  Future oncology (London, England)  Jan 2018 
 - 123-136 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1744-8301 
<br/><br/><label>Standard No.: </label>10.2217/fon-2017-0379  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Drug Resistance, Neoplasm--genetics<br/>Female<br/>Folate Receptor 1--antagonists & inhibitors<br/>Humans<br/>Immunoconjugates--immunology<br/>Maytansine--analogs & derivatives<br/>Ovarian Neoplasms--drug therapy<br/>Platinum--adverse effects